SECONDARY GLIOBLASTOMA

Clinical trials for SECONDARY GLIOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new SECONDARY GLIOBLASTOMA trials appear

Sign up with your email to follow new studies for SECONDARY GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope: immune therapy targets aggressive recurrent brain tumors

Disease control Ongoing

This study tests whether two immunotherapy drugs (ipilimumab and nivolumab) can help control recurrent, aggressive brain tumors that have many genetic mutations. The treatment aims to help the body's immune system recognize and attack the cancer cells. Researchers are measuring w…

Matched conditions: SECONDARY GLIOBLASTOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

SECONDARY GLIOBLASTOMA

Get alerted when new SECONDARY GLIOBLASTOMA trials appear

New hope: immune therapy targets aggressive recurrent brain tumors